Key result
Overexpression of the mutant CG8111 p.S333L in Drosophila caused 100% lethality during development, growth defects, and cardiac arrhythmias in males, mimicking features of human ARVC5.
Why the study?
Arrhythmogenic right ventricular cardiomyopathy type 5 is associated with the TMEM43 p.S358L mutation, but the molecular functions and etiology remained to be fully assessed in a Drosophila model.
Answers are grounded in this paper and cite their sources.
The Drosophila model of the TMEM43 p.S358L variant recapitulates key features of ARVC5, including male-predominant arrhythmias and metabolic impairments, providing a novel platform for studying the disease mechanism.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a severe cardiac disease that leads to heart failure or sudden cardiac death (SCD). For the pathogenesis of ARVC, various mutations in at least eight different genes have been identified. A rare form of ARVC is associated with the mutation TMEM43 p.S358L, which is a fully penetrant variant in male carriers. TMEM43 p.S358 is homologous to CG8111 p.S333 in Drosophila melanogaster. We established CRISPR/Cas9-mediated CG8111 knock-out mutants in Drosophila, as well as transgenic fly lines carrying an overexpression construct of the CG8111 p.S333L substitution. Knock-out flies developed normally, whereas the overexpression of CG8111 p.S333L caused growth defects, loss of body weight, cardiac arrhythmias, and premature death. An evaluation of a series of model mutants that replaced S333 by selected amino acids proved that the conserved serine is critical for the physiological function of CG8111. Metabolomic and proteomic analyses revealed that the S333 in CG8111 is essential to proper energy homeostasis and lipid metabolism in the fly. Of note, metabolic impairments were also found in the murine Tmem43 disease model, and fibrofatty replacement is a hallmark of human ARVC5. These findings contribute to a more comprehensive understanding of the molecular functions of CG8111 in Drosophila, and can represent a valuable basis to assess the aetiology of the human TMEM43 p.S358L variant in more detail.
No takes yet. Share an insight, caveat, or question.
Klinke et al. (2022) studied Arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5). CG8111 p.S333L overexpression vs. Wild-type CG8111 overexpression or control flies was evaluated on Lethality, growth defects, and cardiac arrhythmias. Overexpression of the mutant CG8111 p.S333L in Drosophila caused 100% lethality during development, growth defects, and cardiac arrhythmias in males, mimicking features of human ARVC5.
Synapse has enriched 10 related papers. Consider them for comparative context: